menu search

FREQ / Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The Phase 1b study, FX-322, was associated with a hearing signal, as shown by improvements by four subjects in a sentence-in-noise test. Read More
Posted: Dec 9 2021, 13:18
Author Name: Benzinga
Views: 091961

FREQ News  

Frequency (FREQ) Up 77% on Merger Deal With Korro Bio

By Zacks Investment Research
July 17, 2023

Frequency (FREQ) Up 77% on Merger Deal With Korro Bio

Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will a more_horizontal

Why Is Frequency Therapeutics (FREQ) Stock Up 44% Today?

By InvestorPlace
July 14, 2023

Why Is Frequency Therapeutics (FREQ) Stock Up 44% Today?

Frequency Therapeutics (NASDAQ: FREQ ) stock is rocketing higher on Friday following news that it will combine with Korro Bio . This merger plan is d more_horizontal

FREQ Stock: 80.54% Plummet Explanation

By Pulse2
February 13, 2023

FREQ Stock: 80.54% Plummet Explanation

The stock price of Frequency Therapeutics Inc (NASDAQ: FREQ) plummeted 80.54% in the most recent trading session. This is why. more_horizontal

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

By Benzinga
December 9, 2021

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

By Benzinga
December 9, 2021

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

By Benzinga
December 9, 2021

Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise

Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal


Search within

Pages Search Results: